Barkhof F - Search Results

1

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis.

Geraldes R, Juryńczyk M, Dos Passos G, Prichler A, Chung K, Hagens M, Ruggieri S, Huerga E, Sastre-Garriga J, Enzinger C, Chard DT, Barkhof F, Gasperini C, Rovira A, DeLuca GC, Palace J; MAGNIMS study group. Geraldes R, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):388-391. doi: 10.1136/jnnp-2019-322369. Epub 2020 Feb 7. J Neurol Neurosurg Psychiatry. 2020. PMID: 32034114

2

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Barkhof F, Frequin ST, Hommes OR, Lamers K, Scheltens P, van Geel WJ, Valk J. Barkhof F, et al. Neurology. 1992 Jan;42(1):63-7. doi: 10.1212/wnl.42.1.63. Neurology. 1992. PMID: 1370864

3

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC. Scheltens P, et al. Among authors: barkhof f. Brain. 1992 Jun;115 ( Pt 3):735-48. doi: 10.1093/brain/115.3.735. Brain. 1992. PMID: 1628199

4

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.

Barkhof F, Hommes OR, Scheltens P, Valk J. Barkhof F, et al. Neurology. 1991 Aug;41(8):1219-22. doi: 10.1212/wnl.41.8.1219. Neurology. 1991. PMID: 1866009

5

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Miller DH, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):683-8. doi: 10.1136/jnnp.54.8.683. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940938 Free PMC article.

6

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. van Walderveen MA, et al. Among authors: barkhof f. Neurology. 1995 Sep;45(9):1684-90. doi: 10.1212/wnl.45.9.1684. Neurology. 1995. PMID: 7675227

7

Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging.

Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W. Scheltens P, et al. Among authors: barkhof f. Neurology. 1995 May;45(5):883-8. doi: 10.1212/wnl.45.5.883. Neurology. 1995. PMID: 7746401

8

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: barkhof f. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

9

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.

Miller DH, Barkhof F, Nauta JJ. Miller DH, et al. Among authors: barkhof f. Brain. 1993 Oct;116 ( Pt 5):1077-94. doi: 10.1093/brain/116.5.1077. Brain. 1993. PMID: 8221048

10

Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis.

van Walderveen MA, Tas MW, Barkhof F, Polman CH, Frequin ST, Hommes OR, Valk J. van Walderveen MA, et al. Among authors: barkhof f. Neurology. 1994 Feb;44(2):327-9. doi: 10.1212/wnl.44.2.327. Neurology. 1994. PMID: 8309584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,501 results

Search Page

Filters